AAAAAA

   
Results: 1-8 |
Results: 8
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
Authors: van der Burg, SH Kwappenberg, KMC O'Neill, T Brandt, RMP Melief, CJM Hickling, JK Offringa, R
Citation: Sh. Van Der Burg et al., Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens, VACCINE, 19(27), 2001, pp. 3652-3660
Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes
Authors: van der Burg, SH Ressing, ME Kwappenberg, KMC de Jong, A Straathof, K de Jong, J Geluk, A van Meugaarden, KE Franken, KLMC Ottenhoff, THM Fleuren, GJ Kenter, G Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes, INT J CANC, 91(5), 2001, pp. 612-618
Identification of three non-VNTR MUC1-derived HLA-A0201-restricted T-cellepitopes that induce protective anti-tumor immunity in HLA-A2/K-b-transgenic mice
Authors: Heukamp, LC van der Burg, SH Drijfhout, JW Melief, CJM Taylor-Papadimitriou, J Offringa, R
Citation: Lc. Heukamp et al., Identification of three non-VNTR MUC1-derived HLA-A0201-restricted T-cellepitopes that induce protective anti-tumor immunity in HLA-A2/K-b-transgenic mice, INT J CANC, 91(3), 2001, pp. 385-392
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer
Authors: van der Burg, SH de Cock, K Menon, AG Franken, KLMC Palmen, M Redeker, A Drijfhout, JW Kuppen, PJK van de Velde, CJH Erdile, L Tollenaar, RAEM Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer, EUR J IMMUN, 31(1), 2001, pp. 146-155
Design and evaluation of antigen-specific vaccination strategies against cancer
Authors: Offringa, R van der Burg, SH Ossendorp, F Toes, REM Melief, CJM
Citation: R. Offringa et al., Design and evaluation of antigen-specific vaccination strategies against cancer, CURR OP IM, 12(5), 2000, pp. 576-582
Importance of CD4(+) T helper cell responses in tumor immunity
Authors: Ossendorp, F Toes, REM Offringa, R van der Burg, SH Melief, CJM
Citation: F. Ossendorp et al., Importance of CD4(+) T helper cell responses in tumor immunity, IMMUNOL LET, 74(1), 2000, pp. 75-79
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T cells by at least four unrelated HLA-DR molecules
Authors: van der Burg, SH Kwappenberg, KMC Geluk, A van der Kruk, M Pontesilli, O Hovenkamp, E Franken, KLMC van Meijgaarden, KE Drijfhout, JW Ottenhoff, THM Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T cells by at least four unrelated HLA-DR molecules, J IMMUNOL, 162(1), 1999, pp. 152-160
Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
Authors: Kammer, AR van der Burg, SH Grabscheid, B Hunziker, IP Kwappenberg, KMC Reichen, J Melief, CJM Cerny, A
Citation: Ar. Kammer et al., Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition, J EXP MED, 190(2), 1999, pp. 169-176
Risultati: 1-8 |